Maximos, S.; Chamoun, M.; Gravel, S.; Turgeon, J.; Michaud, V.
Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues. Pharmaceutics 2017, 9, 40.
https://doi.org/10.3390/pharmaceutics9040040
AMA Style
Maximos S, Chamoun M, Gravel S, Turgeon J, Michaud V.
Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues. Pharmaceutics. 2017; 9(4):40.
https://doi.org/10.3390/pharmaceutics9040040
Chicago/Turabian Style
Maximos, Sarah, Michel Chamoun, Sophie Gravel, Jacques Turgeon, and Veronique Michaud.
2017. "Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues" Pharmaceutics 9, no. 4: 40.
https://doi.org/10.3390/pharmaceutics9040040
APA Style
Maximos, S., Chamoun, M., Gravel, S., Turgeon, J., & Michaud, V.
(2017). Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues. Pharmaceutics, 9(4), 40.
https://doi.org/10.3390/pharmaceutics9040040